Lunsumio Velo

Genentech, Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 29, 2026
Approval ID: 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8
Products: 2 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LUNSUMIO VELO safely and effectively. See full prescribing information for LUNSUMIO VELO. LUNSUMIO VELO™ (mosunetuzumab-axgb) injection, for subcutaneous use Initial U.S. Approval: 2022

Quick Stats

Total Products2

Labelers1

Label Sections37

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.